Latest Regulatory News

EV Resources Limited has finalized its acquisition of a 70% interest in the Los Lirios Antimony Mine in Oaxaca, Mexico, marking a strategic move to bolster critical mineral supply in the Americas. The company is advancing ore testing and plans to develop processing capabilities aligned with local community priorities.

Island Pharmaceuticals has reported encouraging Phase 2a/b trial results for ISLA-101, demonstrating meaningful reductions in dengue viral load and symptoms in humans. The findings support further clinical development of this antiviral candidate.

Macquarie Group Limited has announced a quarterly ordinary dividend of AUD 1.7239 per CAP Note security, payable in September 2025, with partial franking and a total distribution rate of 6.84% per annum.

EVE Health Group has completed its acquisition of Nextract Pty Ltd, positioning itself to enter the lucrative erectile dysfunction and dysmenorrhea markets with innovative drug delivery technologies.

AnteoTech secures a significant purchase order from the Serum Institute of India, driving its Life Sciences unit toward a projected 130% sales increase in FY2025 despite some project delays.

BPH Global Ltd has completed its second seaweed sale under a strategic partnership in Indonesia, marking steady progress in its supply network expansion and operational execution.

Australian Critical Minerals has agreed to acquire Circuit Resources, gaining a substantial portfolio of gold, copper, silver, zinc, lead, and lithium projects in Peru, unlocking immediate drill-ready targets with significant exploration upside.

Southern Palladium has raised A$8 million through a strategic placement to accelerate its Definitive Feasibility Study and staged mine development at the Bengwenyama PGM project, backed by a major cornerstone investor.

ASX Limited’s 2025 Investor Forum reveals steady progress on its five-year strategy, highlighting technology modernization, operational risk management, and a focus on data-driven growth. The exchange outlines capital expenditure plans and expense controls aimed at sustaining shareholder value amid evolving market demands.

Aguia Resources is ramping up production at its high-grade Santa Barbara gold project in Colombia while advancing a low-capital phosphate operation in Brazil, setting the stage for robust cash flow generation.

ASX Limited reveals steady progress on its FY28 strategy, emphasizing technology modernization and operational resilience while providing detailed financial guidance through FY27.

Cleo Diagnostics unveils a pioneering blood test for early ovarian cancer detection, boasting superior accuracy to existing methods and targeting a significant U.S. market opportunity.